For in vitro diagnostic use. Others Elecsys CYFRA 21-1 IVD Elecsys® CYFRA 21-1 CPS_000462 07 299 966 188 7 299 966 188 07299966188 7299966188 07299966188 Cyfra 21-1 Elecsys E2G 300 Elecsys CYFRA 21-1 07613336193761 Reagents, kits 300 tests cobas e 402/801 true 11 820 966 188 11820966188 Cyfra 21-1 Elecsys cobas e 100 Elecsys CYFRA 21-1 07613336162958 Reagents, kits 100 tests cobas e 411/601/602 07 299 966 214 7 299 966 214 07299966214 7299966214 07299966214 Cyfra 21-1 Elecsys E2G 300 Elecsys CYFRA 21-1 07613336193754 Reagents, kits 300 tests cobas e 402/801 true 11 820 966 160 11820966160 Cyfra 21-1 Elecsys cobas e 100 Elecsys CYFRA 21-1 04015630934805 Reagents, kits 100 tests cobas e 411/601/602 true 11 820 966 214 11820966214 Cyfra 21-1 Elecsys cobas e 100 Elecsys CYFRA 21-1 07613336162965 Reagents, kits 100 tests cobas e 411/601/602 true 07 299 966 190 7 299 966 190 07299966190 7299966190 07299966190 Cyfra 21-1 Elecsys E2G 300 Elecsys CYFRA 21-1 04015630940004 Reagents, kits 300 tests cobas e 402/801 true 11 820 966 122 11820966122 Cyfra 21-1 Elecsys cobas e 100 Elecsys CYFRA 21-1 04015630909827 Reagents, kits 100 tests cobas e 411/601/602 true 11820966500 Elecsys CYFRA 21-1 en 23 FF0000000552880E FF0000000552880E 11820966122 11820966188 11820966214 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of fragments of cytokeratin 19 in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en MS_08541701001 Elecsys CYFRA 21-1 en 1 FF000000052B3F0E FF000000052B3F0E 11820966122 11820966188 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. 07299966500 Elecsys CYFRA 21-1 en 9 FF0000000670F40E FF000000060EE70E 07299966190 07299966214 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of fragments of cytokeratin 19 in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 07299966500 Elecsys CYFRA 21-1 en 8 FF000000060EE70E FF0000000441620E 07299966190 07299966214 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of fragments of cytokeratin 19 in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 11820966501 Elecsys CYFRA 21-1 en 2 FF00000006E5FB0E FF00000001C5F50E 11820966160 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of fragments of cytokeratin 19 in human serum and plasma (Li‑heparin, K2‑EDTA and K3‑EDTA). The assay is to be used as an aid in monitoring disease progression during the course of disease and treatment in lung cancer patients. Serial testing for patient CYFRA 21‑1 assay values should be used in conjunction with other clinical methods used for monitoring lung cancer.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 07299966501 Elecsys CYFRA 21-1 en 2 FF0000000531D30E FF00000001E3820E 07299966190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of fragments of cytokeratin 19 in human serum and plasma (Li‑heparin, K2‑EDTA and K3‑EDTA). The assay is to be used as an aid in monitoring disease progression during the course of disease and treatment in lung cancer patients. Serial testing for patient CYFRA 21‑1 assay values should be used in conjunction with other clinical methods used for monitoring lung cancer.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 11820966500 Elecsys CYFRA 21-1 en 21 FF00000003E7BD0E FF00000000291D0E 11820966122 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of fragments of cytokeratin 19 in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en

User Profile

Select your user profile

Elecsys^® CYFRA 21-1

Overview

Detailed Specifications

Ordering Information

Compatible Instruments

Technical Documents

Access important product documentation including relevant certificates and other resources.